Product image of Lanzostad (Lansoprazole) supplied by GNH India

Lanzostad

Active Ingredient:
Lansoprazole
Origin:
EU

Lanzostad (Lansoprazole)

Lansoprazole, the active ingredient in Lanzostad, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is used to manage conditions such as gastro‑esophageal reflux disease, peptic ulcer disease, erosive esophagitis and Helicobacter pylori eradication regimens in adult patients.

GNH India supplies Lanzostad as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for bulk and packaged orders across multiple regions.

Manufacturer / TM Owner

Stada Arzneimittel Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lansoprazole acts on the gastric acid‑secretion pathway and is indicated for several acid‑related disorders.

  • Gastro‑esophageal reflux disease (GERD): provides symptomatic relief by decreasing reflux‑related heartburn and regurgitation.
  • Peptic ulcer disease: promotes ulcer healing by maintaining a higher gastric pH.
  • Erosive esophagitis: facilitates mucosal recovery through sustained acid suppression.
  • Helicobacter pylori eradication regimens: enhances antibiotic efficacy when used as part of combination therapy.

How It Works

  • Lansoprazole selectively and irreversibly inhibits the H⁺/K⁺‑ATPase enzyme (the gastric proton pump) located on the secretory surface of parietal cells. By blocking this final step of acid production, it markedly reduces both basal and stimulated gastric acid secretion, leading to an increased intragastric pH that supports healing of acid‑induced lesions. The inhibition persists for up to 72 hours, allowing once‑daily dosing in most treatment protocols.

Side Effects

Lansoprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Headache: mild, transient pain in the head.
  • Diarrhea: loose stools occurring during treatment.
  • Nausea: feeling of sickness or urge to vomit.
  • Abdominal pain: discomfort or cramps in the stomach area.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or difficulty breathing.
  • Clostridioides difficile infection: persistent watery diarrhea with abdominal cramping.
  • Low magnesium levels: muscle weakness, irregular heartbeat, or seizures.

Precautions & Warnings

Before prescribing Lansoprazole, clinicians should consider several safety precautions.

  • Assess renal function: adjust use in patients with severe impairment.
  • Monitor magnesium: prolonged therapy may cause hypomagnesemia.
  • Evaluate for infection risk: acid suppression can increase susceptibility to gastrointestinal infections.
  • Use cautiously in the elderly: higher incidence of bone fractures reported.
  • Avoid concomitant use with drugs that require gastric acidity for absorption unless medically necessary.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Lansoprazole can affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid)

  • Clopidogrel: reduced antiplatelet effect.
  • Atazanavir: markedly decreased antiviral exposure.
  • Methotrexate: increased toxicity risk due to reduced clearance.

Moderate Interactions (Monitor Closely)

  • Digoxin: modest increase in serum levels.
  • Phenytoin: decreased anticonvulsant concentrations.
  • Oral contraceptives: possible reduction in hormonal efficacy.

Frequently Asked Questions

Lanzostad contains lansoprazole, which is prescribed to treat gastro‑esophageal reflux disease, peptic ulcer disease, erosive esophagitis, and to support Helicobacter pylori eradication regimens when used with appropriate antibiotics.

Lansoprazole blocks the H⁺/K⁺‑ATPase enzyme, also known as the gastric proton pump, on parietal cells. This inhibition stops the final step of acid production, leading to a sustained increase in gastric pH and reduced acidity.

The specific dose of Lanzostad is determined by the prescribing clinician based on the patient’s condition, severity, and response to therapy. Dosage instructions are individualized and should follow the prescriber’s recommendation.

Safety data for lansoprazole in pregnancy and lactation are limited. The prescriber should evaluate the potential benefits against any possible risks before prescribing to pregnant or nursing mothers.

To place an order, submit an enquiry on the Lanzostad product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Lanzostad (lansoprazole) belongs to the proton pump inhibitor class, offering more potent and longer‑lasting acid suppression than H₂‑blockers such as ranitidine. Compared with other PPIs, its efficacy and safety profile are similar, with choice often guided by patient response, drug‑interaction potential and formulary considerations.

Lanzostad should be stored at room temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat and direct sunlight to maintain product stability.

Lanzostad is taken orally, usually as a whole tablet with a glass of water. It can be taken with or without food, but consistency with respect to meals helps maintain predictable absorption.

Serious risks, though uncommon, include severe allergic reactions, Clostridioides difficile‑associated diarrhea, and significant electrolyte disturbances such as low magnesium, which can cause muscle weakness, irregular heartbeat or seizures.

Patients with known hypersensitivity to lansoprazole or any component of the formulation should avoid Lanzostad. Caution is also advised for individuals with severe liver disease, those on interacting medications, and patients at high risk for bone fractures.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lansoprazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT